Repligen Corp
NASDAQ:RGEN

Watchlist Manager
Repligen Corp Logo
Repligen Corp
NASDAQ:RGEN
Watchlist
Price: 120.21 USD -5.78% Market Closed
Market Cap: 6.8B USD

Wall Street
Price Targets

RGEN Price Targets Summary
Repligen Corp

Wall Street analysts forecast RGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RGEN is 187.27 USD with a low forecast of 141.4 USD and a high forecast of 231 USD.

Lowest
Price Target
141.4 USD
18% Upside
Average
Price Target
187.27 USD
56% Upside
Highest
Price Target
231 USD
92% Upside
Repligen Corp Competitors:
Price Targets
688315
Novogene Co Ltd
7% Upside
INNOVACAP
Innova Captab Ltd
30% Upside
BIOT
Biotage AB
3% Upside
DXRX
Diaceutics PLC
46% Upside
AZTA
Azenta Inc
83% Upside
LAB
Standard BioTools Inc
133% Upside
ERF
Eurofins Scientific SE
6% Upside
4880
CellSource Co Ltd
39% Upside

Revenue
Forecast

Revenue Estimate
Repligen Corp

For the last 8 years the compound annual growth rate for Repligen Corp's revenue is 25%. The projected CAGR for the next 3 years is 15%.

25%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Repligen Corp

For the last 8 years the compound annual growth rate for Repligen Corp's operating income is -6%. The projected CAGR for the next 3 years is 149%.

-6%
Past Growth
149%
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Net Income
Forecast

Net Income Estimate
Repligen Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-40%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RGEN's stock price target?
Price Target
187.27 USD

According to Wall Street analysts, the average 1-year price target for RGEN is 187.27 USD with a low forecast of 141.4 USD and a high forecast of 231 USD.

What is Repligen Corp's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Repligen Corp's revenue is 25%. The projected CAGR for the next 3 years is 15%.

What is Repligen Corp's Operating Income forecast?
Projected CAGR
149%

For the last 8 years the compound annual growth rate for Repligen Corp's operating income is -6%. The projected CAGR for the next 3 years is 149%.

Back to Top